Loading
Latest filing published 19 Feb 2026 for AEON Biopharma, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Robert E. Bancroft in AEON Biopharma, Inc. Over a trading history stretching from 14 May 2025 to 17 February 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 February 2026, reports a share grant in AEON Biopharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations